Literature DB >> 16102265

Absorption characteristics of model compounds from the small intestinal serosal surface and a comparison with other organ surfaces.

Koyo Nishida1, Akiko Kuma, Shintaro Fumoto, Mikiro Nakashima, Hitoshi Sasaki, Junzo Nakamura.   

Abstract

We examined the absorption of phenolsulfonphthalein (PSP) and fluorescein isothiocyanate dextrans (FD-4, MW 4400; FD-10, MW 9500; FD-40, MW 40 500) as model compounds through the small intestinal serosal surface. After application to the rat small intestinal serosal surface using a cylindrical diffusion cell, each compound was absorbed at different rates. The absorption ratios in 6 h after PSP, FD-4, FD-10 and FD-40 application were calculated to be 89.2, 34.6, 14.9 and 2.1% of dose, respectively. Elimination profiles of PSP, FD-4 and FD-10 from the small intestinal serosal surface obeyed first-order kinetics. Moreover, we calculated the apparent permeability coefficient P(app) for comparison to other organ surfaces. The kidney had the highest absorption efficiency, as shown by having more than 1.5 times significantly higher P(app) values of PSP, FD-4 and FD-10. Similar to the other organ surfaces, a correlation was observed between the P(app) of the small intestine and the molecular weight of these hydrophilic compounds. In addition, the small intestine is likely to contribute largely to hydrophilic compound absorption from the peritoneal cavity, judging from absorption clearance, CL(a), calculated using the peritoneal organ surface area.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16102265     DOI: 10.1211/0022357056677

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  3 in total

1.  Evaluation of enhanced peritoneum permeability in methylglyoxal-treated rats as a diagnostic method for peritoneal damage.

Authors:  Shintaro Fumoto; Yukiko Nakashima; Koyo Nishida; Yukinobu Kodama; Junya Nishi; Mikiro Nakashima; Hitoshi Sasaki; Noboru Otsuka; Junzo Nakamura
Journal:  Pharm Res       Date:  2007-05-03       Impact factor: 4.200

2.  Effects of carrier on disposition and antitumor activity of intraperitoneal Paclitaxel.

Authors:  Max Tsai; Ze Lu; Jie Wang; Teng-Kuang Yeh; M Guillaume Wientjes; Jessie L-S Au
Journal:  Pharm Res       Date:  2007-04-20       Impact factor: 4.200

3.  Dextran-Mimetic Quantum Dots for Multimodal Macrophage Imaging In Vivo, Ex Vivo, and In Situ.

Authors:  Hongping Deng; Christian J Konopka; Suma Prabhu; Suresh Sarkar; Natalia Gonzalez Medina; Muhammad Fayyaz; Opeyemi H Arogundade; Hashni Epa Vidana Gamage; Sayyed Hamed Shahoei; Duncan Nall; Yeoan Youn; Iwona T Dobrucka; Christopher O Audu; Amrita Joshi; William J Melvin; Katherine A Gallagher; Paul R Selvin; Erik R Nelson; Lawrence W Dobrucki; Kelly S Swanson; Andrew M Smith
Journal:  ACS Nano       Date:  2022-02-02       Impact factor: 15.881

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.